• Alvaro Mesoraca, Katia Margiotti, Antonella Viola, Antonella Cima, Davide Sparacino, and Claudio Giorlandino.
• ALTAMEDICA, Human Genetics laboratories, Altamedica Main Centre, Artemisia SpA, Viale Liegi 45, 00198, Rome, Italy.
• Virol J. 2020 Jun 30; 17 (1): 86.

AbstractThe need for timely establishment of a complete diagnostic protocol of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is demanded worldwide. We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom. Initially, fecal samples were negative in the 67% (10/15) of the cases, while 33% (5/10) of the cases were positive. After serial virus RNA testing, 73% (11/15) of the cases resulted positive to fecal specimens. In particular, 15 days after the first positive respiratory specimens test, 6 fecal specimens became positive for SARS-CoV-2 RNA, while 13 respiratory test returned negative result. In conclusion, qRT-PCR assays of fecal specimens, is an important step to control infection, suggesting that samples remained positive for SARS-CoV-2 RNA longer time then respiratory tract samples. Our results enhance the recent knowledge on this emerging infectious disease and offer suggestions for a more complete diagnostic strategy.

31 keywords...

hide…